Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q1 2024 Earnings Call Transcript May 14, 2024 Atea Pharmaceuticals, Inc. misses on ...

By reducing these symptoms, a patient's physical function can be improved. In some patients, intolerability to NSAIDs can limit the options for treating their OA symptoms. All NSAIDs carry a risk ...

014). Discontinuations for medication intolerability were not different between groups (P = .320). The mean modal dose of olanzapine for the black patient group was 15.5 mg (SD = 4.3) and was 15.3 ...

Treatment continued for a maximum of 108 weeks or until unacceptable toxicity, disease progression, or intolerability. The trial’s primary end point was the rate of patients with a CR or CR with ...

Intolerability: If your skin doesn't tolerate retinoids, even at low strengths, a healthcare provider may suggest stopping treatment. Adapalene is generally the better option for acne treatment. If ...

and subjective measures of intolerability (nausea) are not.32 This highlights a limitation of the current study, in that the data were originally collected for the purpose of analysing longitudinal ...

The patients' adherence to anti-rheumatic therapy was significantly (p<0.1) higher in group I whereas stopping DMARDs for intolerability was significantly (p<0.01) higher in group II at both 6- and 12 ...

Patients were excluded from the analysis if disease-modifying agents, for example, tocilizumab, were initially added in patients with strong risk factors for glucocorticoid-related AEs or ...

Adapalene and retinol are sometimes confused with one another. Adapalene (brand name: Differin) is a type of retinoid. While retinol is naturally available, it can also be a type of retinoid when ...